Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| cardiac muscle cell | 6 studies | 82% ± 13% | |
| glutamatergic neuron | 3 studies | 23% ± 4% | |
| endothelial cell | 3 studies | 24% ± 8% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| heart | 5 studies | 35% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 78% | 389.31 | 512 / 653 | 30% | 0.74 | 180 / 605 |
| uterus | 87% | 1004.15 | 148 / 170 | 21% | 1.34 | 95 / 459 |
| ovary | 95% | 900.27 | 171 / 180 | 10% | 0.25 | 44 / 430 |
| esophagus | 83% | 1049.73 | 1202 / 1445 | 19% | 0.45 | 35 / 183 |
| pancreas | 95% | 4261.33 | 312 / 328 | 7% | 0.12 | 12 / 178 |
| muscle | 100% | 2537.62 | 803 / 803 | 0% | 0 | 0 / 0 |
| heart | 99% | 8041.10 | 853 / 861 | 0% | 0 | 0 / 0 |
| kidney | 30% | 109.03 | 27 / 89 | 66% | 2.48 | 595 / 901 |
| skin | 44% | 247.70 | 805 / 1809 | 44% | 2.37 | 206 / 472 |
| intestine | 74% | 911.00 | 714 / 966 | 3% | 0.06 | 14 / 527 |
| breast | 46% | 240.53 | 211 / 459 | 30% | 2.64 | 334 / 1118 |
| eye | 0% | 0 | 0 / 0 | 74% | 2.72 | 59 / 80 |
| blood vessel | 73% | 1266.47 | 978 / 1335 | 0% | 0 | 0 / 0 |
| prostate | 64% | 490.06 | 158 / 245 | 7% | 0.15 | 36 / 502 |
| bladder | 62% | 349.95 | 13 / 21 | 8% | 0.33 | 42 / 504 |
| adipose | 64% | 377.35 | 775 / 1204 | 0% | 0 | 0 / 0 |
| stomach | 50% | 229.03 | 178 / 359 | 6% | 0.27 | 17 / 286 |
| lung | 33% | 256.20 | 192 / 578 | 12% | 0.37 | 141 / 1155 |
| brain | 20% | 101.27 | 530 / 2642 | 19% | 0.32 | 135 / 705 |
| adrenal gland | 0% | 1.38 | 1 / 258 | 19% | 0.40 | 43 / 230 |
| tonsil | 0% | 0 | 0 / 0 | 18% | 0.31 | 8 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 14% | 0.45 | 4 / 29 |
| liver | 0% | 0 | 0 / 226 | 8% | 0.20 | 32 / 406 |
| peripheral blood | 1% | 2.92 | 8 / 929 | 0% | 0 | 0 / 0 |
| spleen | 0% | 1.40 | 1 / 241 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0043484 | Biological process | regulation of RNA splicing |
| GO_0033120 | Biological process | positive regulation of RNA splicing |
| GO_0048025 | Biological process | negative regulation of mRNA splicing, via spliceosome |
| GO_0060914 | Biological process | heart formation |
| GO_0008380 | Biological process | RNA splicing |
| GO_0048024 | Biological process | regulation of mRNA splicing, via spliceosome |
| GO_0006397 | Biological process | mRNA processing |
| GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
| GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
| GO_0005634 | Cellular component | nucleus |
| GO_0097157 | Molecular function | pre-mRNA intronic binding |
| GO_1990935 | Molecular function | splicing factor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003729 | Molecular function | mRNA binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0003723 | Molecular function | RNA binding |
| Gene name | RBM20 |
| Protein name | RNA binding motif protein 20 Truncated RNA binding motif protein 20 RNA-binding protein 20 (RNA-binding motif protein 20) |
| Synonyms | |
| Description | FUNCTION: RNA-binding protein that acts as a regulator of mRNA splicing of a subset of genes encoding key structural proteins involved in cardiac development, such as TTN (Titin), CACNA1C, CAMK2D or PDLIM5/ENH . Acts as a repressor of mRNA splicing: specifically binds the 5'UCUU-3' motif that is predominantly found within intronic sequences of pre-mRNAs, leading to the exclusion of specific exons in target transcripts . RBM20-mediated exon skipping is hormone-dependent and is essential for TTN isoform transition in both cardiac and skeletal muscles . RBM20-mediated exon skipping of TTN provides substrates for the formation of circular RNA (circRNAs) from the TTN transcripts . Together with RBM24, promotes the expression of short isoforms of PDLIM5/ENH in cardiomyocytes (By similarity). . |
| Accessions | Q5T481 ENST00000369519.4 A0A7R6RR32 A0A7R6M6R7 A0A7R6M8M5 A0A7R6RQJ6 |